Cancer therapy with vaccination using HLA-A02-restricted peptide from RNF43: a phase I study in patients with unresectable colorectal cancer
Ontology highlight
ABSTRACT: Interventions: Vaccination using epitope peptide from RNF43
Primary outcome(s): safety
Study Design: Single arm Non-randomized
DISEASE(S): Unresectable Colorectal Cancer
PROVIDER: 2616205 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA